Sbs Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-06-2024
- Paid Up Capital ₹ 0.10 M
as on 21-06-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 34581.60%
(FY 2020)
- Profit 1313.98%
(FY 2020)
- Ebitda 539.27%
(FY 2020)
- Net Worth 178.36%
(FY 2020)
- Total Assets 5525.28%
(FY 2020)
About Sbs Life Sciences
The Corporate was formerly known as Salubrious Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sbs Life Sciences Private Limited India is Somasekharam Asapu as CEO. Sunkara Raju, Roja Ankam, and Somasekharam Asapu serve as directors at the Company.
- CIN/LLPIN
U33309TG2016PTC111000
- Company No.
111000
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jul 2016
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sbs Life Sciences Private Limited offer?
Sbs Life Sciences Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Multivitamin Syrup & Drops, Vitamin D3 Drops, Fertility Enhancer, Progesterone Capsules, Healthcare Products & Aids, Health Drinks, Antibacterial Drugs, Ofloxacin Tablet IP.
Who are the key members and board of directors at Sbs Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Somasekharam Asapu  | CEO | 19-Jul-2016 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunkara Raju | Director | 07-Sep-2019 | Current |
| Roja Ankam | Director | 19-Jul-2016 | Current |
Financial Performance and Corporate Structure Insights of Sbs Life Sciences.
Sbs Life Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 34581.6% increase. The company also saw a substantial improvement in profitability, with a 1313.98% increase in profit. The company's net worth Soared by an impressive increase of 178.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sbs Life Sciences?
In 2020, Sbs Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sbs Life Sciences?
Sbs Life Sciences has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sbs Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sbs Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
